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I Health, Education, and Welfare
Reforming Medicare: Options, Tradeoffs, and 
Opportunities. By Henry J. Aaron and Jeanne 
M. Lambrew. With Patrick F. Healey. A 
Century Foundation Book. Washington, D.C.: 
Brookings Institution Press, 2008. Pp. xi, 202. 
$28.95. ISBN 978–0–8157–0124–8. 
 JEL 2008–1315
Medicare needs fixing. The program has its 
strengths; it is popular among beneficiaries, has 
very low administrative costs (maybe too low), 
and, since its inception, has greatly reduced 
financial risk exposure among beneficiaries. 
Nevertheless, it is unaffordable and inefficient. 
Jeanne Lambrew and Henry Aaron take up both 
of these challenges for Medicare reform in great 
detail in Reforming Medicare.
Even for well-seasoned readers of the annual 
health spending accounts, Aaron and Lambrew’s 
table of projected Medicare spending registers 
quite a shock (table 3-4, p. 45). Because predict-
ing cost growth for health care seventy years 
out is a fool’s errand, albeit a legally mandated 
one, one should not worry too much about the 
longest range estimates. The more reliable, near 
term estimates, however, look exceptionally grim. 
Assuming that the only source of cost growth is 
from changes in the number and demographics of 
Medicare beneficiaries related to the inclusion of 
the baby boomers—an unrealistically low rate of 
growth—Medicare spending will account for 3.9 
percent of GDP by 2020 (compared to 3.1 percent 
in 2007). Using CBO projections that assume a 
reduction in physician payments by about 5 per-
cent annually through 2016, a reduction that 
seems implausible given Congress’ inability to 
make such reductions stick in the past, Medicare 
spending will be 4.7 percent of GDP by 2020. If 
these numbers are not sufficiently dramatic to 
rouse the reader, consider that “[b]etween 2008 
and 2018, Medicare’s share of non-interest fed-
eral spending is expected to rise from 14.8 to 17.1 
percent” (p. 9). 
This level of spending may very well be worth 
it (David M. Cutler 2004), but funding must 
be found somewhere. Medicare’s Hospital 
Insurance Trust Fund will spend more than it 
collects in 2009 and, according to its Trustees, 
is once again on its way to insolvency (Trustees 
of the Social Security and Medicare trust funds 
2009). Congress’ response to the Trustee’s even 
gloomier predictions in 1996 and 1997, when the 
reports predicted insolvency in only four or five 
years, was to cut waste, focusing on fraud-ridden 
home health care billings. 
Addressing widespread inefficiencies in 
Medicare, and American medicine more gen-
erally, is a part of the right strategy. Aaron and 
Lambrew survey the many sources of quality 
deficiencies in the health care system: (1) out-
dated treatment, (2) overuse, underuse, and mis-
use, (3) low value spending, (4) iatrogenic injury, 
and (5) dramatic geographic variation in spending 
(p. 33, et seq.). While policymakers have recently 
embraced reductions in small area spending vari-
ation as the magic health reform bullet, Aaron 
and Lambrew offer a more restrained analysis. 
In page after detailed page, they demonstrate 
the difficulty of translating research into quality 
improvements and cost savings, making clear that 
no single policy response will solve our problems 
(see, e.g., p. 42). 
In the heart of the book, Aaron and Lambrew 
outline three possible reforms: strengthening 
Medicare as a social insurance system, premium 
support, and consumer-directed Medicare. 
They argue that although each has its strengths 
and weaknesses, the first—which is based on 
the notion that beneficiaries are entitled to the 
same, defined benefits—is the most promis-
ing. This view turns out to have been prescient. 
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With President Obama’s election, the recent and 
widespread loss of faith in fully private market 
solutions, and a Congress eager for reform, the 
remaining two policy prescriptions are probably 
off the table for Medicare. Aaron and Lambrew’s 
analysis of the remaining two options is nonethe-
less still useful; even if they are not viable as pub-
lic sector reforms for now, they remain models 
for private sector reform. Employers, therefore, 
may wish to consult Reforming Medicare before 
following Whole Foods’ example of addressing 
selection and unsustainable premium growth by 
offering its employees only one plan. The grocery 
chain offers a health savings account coupled 
with Whole Food’s paying the entire premium for 
a high-deductible, catastrophic coverage plan. 
Reforming Medicare is essential reading for 
anyone who wants to understand the background 
of the current health care reform urgency. It is 
an excellent and current primer for policymak-
ers, benefits managers, students, and scholars. 
Because the authors are central players on the 
Democratic policy stage, the book is also a win-
dow into the thinking and analysis that have 
gone into the current health care reform effort. 
Nevertheless, Reforming Medicare should not be 
read alone.
The major obstacle to reform has not been that 
policymakers (or stakeholders, or even voters) 
cannot reason through the strengths and weak-
nesses or the economic effects of various reform 
proposals. They can, and they do. Decades of 
previous attempts have failed not only because 
health care is complex, but also because of the 
“limitations of our political system and the power 
of the interest groups—doctors, hospitals, insur-
ers, drug companies, researchers, and even 
patient advocates—that have a direct stake in 
it” (Tom Daschle 2008, p. xiii). It is the political 
economy of health reform, not only the techni-
cal policy prescriptions, that desperately needs 
our attention. Fortunately, Lambrew addresses 
these issues in another, albeit less scholarly, book 
on health reform that she published last year—
Critical: What We Can Do about the Health-
Care Crisis, by Senator Tom Daschle with Scott 
Greenberger and Lambrew. 
All reforms have winners and losers, and those 
parties are paying more attention to the techni-
cal details of health policy than almost all other 
Americans. This has been true since the start 
of Medicare, and has continued to make it dif-
ficult for Congress to base its decisions on the 
best scientific evidence regarding cost or medi-
cal effectiveness. Organized patient-group advo-
cacy was key to the process that led Congress to 
grant Medicare coverage to anyone diagnosed 
with end-stage renal disease (ESRD), regardless 
of age and despite the fact that ESRD was not a 
uniquely expensive or deadly disease at the time 
(Marilyn Moon 1993). Physician groups have suc-
cessfully lobbied Congress to override Medicare’s 
Sustainable Growth Rate (SGR), the target rate 
of growth in spending on physician services, 
every year since it was passed in 1997 based on 
the argument that the formula is flawed.
More recently, there has been widespread 
industry opposition to using comparative effec-
tiveness studies in making coverage determina-
tions. Congress overcame opposition to provisions 
in the stimulus bill that would fund new com-
parative effectiveness research, but attempts at 
broadening the role of such research in the health 
system will be opposed by advocates who worry 
that it will be used to restrict Medicare cover-
age decisions (Jerry Avorn 2009). Similarly, the 
Centers for Medicare and Medicaid, which may 
only approve new treatments within benefit cat-
egories (Congress must approve all new benefit 
categories) and must cover treatments that are 
“reasonable and necessary” for diagnosis and 
treatment, has faced strong protest from patient, 
provider, and industry groups when they have 
tried to limit payment for high-cost treatments of 
uncertain benefit, such as anti-anemia bio-phar-
maceuticals and off-label use of colorectal cancer 
chemotherapies (Patricia Seliger Keenan, Peter J. 
Neumann, and Kathryn A. Phillips 2006). 
These examples illustrate why it is critical that, 
in this round of health reform, health policy 
scholars consider not only lessons from health 
economics but also lessons from political econ-
omy. (They will play out dramatically if the tax 
status of health insurance, once seen as sacro-
sanct, remains on the reform table as it seems to 
be now). 
In addition, Critical is a nice place to continue 
where Reforming Medicare leaves off, placing 
Medicare in the context of overall health reform. 
As Aaron and Lambrew conclude:
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Medicare, though important, accounts 
for less than a quarter of personal health 
care spending. Systemic reforms in the U.S. 
health care system would do far more to con-
trol Medicare spending than any reform in 
the program alone. Policies such as promul-
gating an evidence-based benefit design, 
steering patients toward high-value services, 
and reorienting payment policy toward the 
prevention of acute and chronic disease 
have the potential to curtail spending across 
the population, not just among the elderly. 
Systemwide health reform is the best way 
to make Medicare economically sustainable 
and enable it to provide beneficiaries with 
high-quality and affordable health care. (p. 
137, emphasis added)
Medicare faces many of the same problems 
as health insurance for the rest of the popula-
tion, including variation in treatment and qual-
ity, reimbursement linked to individual services 
rather than episodes of illness, and fragmenta-
tion among doctors and payment systems. Since 
“[s]ome of Medicare’s quality shortcomings are 
endemic to the U.S. Health system,” proposals to 
reform Medicare may apply to the entire health 
care system (p. 116). 
But as Aaron and Lambrew note, Medicare 
does not operate in a vacuum. Medicare policy 
affects health care for the nonelderly, and health 
policy for the nonelderly affects Medicare. The 
very enactment of Medicare, for example, had 
enormous spillover effects on the American 
health care system. Amy Finkelstein (2007) has 
estimated that the implementation of Medicare 
caused six times more hospital spending than what 
similar increases in individual insurance take-up, 
rather than through a public program, would have 
predicted. The generosity of the Medicare benefit 
package directly affects the size and characteris-
tics of the retiree population seeking health insur-
ance from their former employers and through 
the private Medigap insurance market. 
Similarly, health policy developments outside 
of the program also affect Medicare. The HMO 
Act of 1973, coupled with ERISA in 1974, paved 
the way for the growth of HMOs within the 
employer-financed health insurance sector that, 
eventually in 1997, led to the introduction of 
Medicare managed care through the introduc-
tion of Medicare Part C (aka “Medicare+Choice,” 
now known as “Medicare Advantage”). A new 
and large group of retirees leaving the private 
work force, where virtually no one gets fee-for-
service medicine, will bring with them their 
expectations that they must ask for permission 
before using health care resources, even if they 
despise doing so. Experience with such tech-
niques among new beneficiaries will likely make 
care management reforms in Medicare more 
politically palatable. 
Reforming Medicare offers a subtle analysis of 
Medicare’s problems and the trade-offs among 
three major approaches to addressing them. As a 
briefing book for a policy analyst, teaching tool, 
or reference, the book has great strengths, includ-
ing its analysis of new programs like Medicare 
Part D. We need answers to questions Aaron and 
Lambrew address, such as “What gets covered?,” 
“How should we decide?,” “How much will it 
cost?,” and “Who pays?” But we also need to know 
what those decisions mean for the distribution 
of health and wealth. Only then can we under-
stand, and engage, the interests that will sup-
port or oppose reform. Fortunately, in addition to 
Reforming Medicare, Lambrew provides another 
source to begin the political economy inquiry. 
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